NADAC acquisition cost data for METFORMIN HCL ER 750 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | Metformin HCL DC Granule 95% |
| Manufacturer | Shouguang Fukang Pharmaceutical Co., Ltd. |
| Dosage Form | POWDER |
| Product Type | BULK INGREDIENT |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 29033005601 | $0.0629 | 2022-12-21 | Rx |
| 29300039901 | $0.0629 | 2022-12-21 | Rx |
| 33342024011 | $0.0629 | 2022-12-21 | Rx |
| 42806063301 | $0.0629 | 2022-12-21 | Rx |
| 49483062401 | $0.0629 | 2022-12-21 | Rx |
| 49483062450 | $0.0629 | 2022-12-21 | Rx |
| 50268055111 | $0.0629 | 2022-12-21 | Rx |
| 50268055115 | $0.0629 | 2022-12-21 | Rx |
| 51224010750 | $0.0629 | 2022-12-21 | Rx |
| 51224010760 | $0.0629 | 2022-12-21 | Rx |
Generic: Metformin HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $257.0M | 91,963 | 24,193 | $36.23 |
| 2020 | $213.5M | 99,446 | 26,319 | $27.92 |
| 2021 | $147.1M | 86,869 | 22,067 | $19.98 |
| 2022 | $148.5M | 80,348 | 20,332 | $21.35 |
| 2023 | $191.1M | 79,353 | 20,436 | $27.17 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.